Altered retinoic acid metabolism in diabetic mouse kidney identified by 18O isotopic labeling and 2D mass spectrometry

PLoS ONE

Volumn 5, Issue 6, 2010, Pages

  Starkey, Jonathan M ^a   Zhao, Yingxin ^a,b   Sadygov, Rovshan G ^a,b   Haidacher, Sigmund J ^a,b   S LeJeune, Wanda ^a,b   Dey, Nilay ^a   Luxon, Bruce A ^a,b   Kane, Maureen A ^c,d   Napoli, Joseph L ^c   Denner, Larry ^a,b   Tilton, Ronald G ^a,b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL DEHYDROGENASE; CELL NUCLEUS RECEPTOR; MESSENGER RNA; OXYGEN 18; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEOME; RETINAL DEHYDROGENASE; RETINOIC ACID; RETINOID BINDING PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATION EXCHANGE; CONTROLLED STUDY; DOWN REGULATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPERGLYCEMIA; IMMUNOFLUORESCENCE; ISOTOPE LABELING; KIDNEY CORTEX; KIDNEY PROXIMAL TUBULE; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN LOCALIZATION; PROTEOMICS; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SEPARATION TECHNIQUE; SIGNAL TRANSDUCTION; TANDEM MASS SPECTROMETRY; UPREGULATION; VITAMIN METABOLISM; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIABETES MELLITUS, EXPERIMENTAL; KIDNEY; MALE; MASS SPECTROMETRY; MICE; MICE, INBRED C57BL; MICROSCOPY, FLUORESCENCE; OXYGEN ISOTOPES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRETINOIN;

MUS;

EID: 77955264766     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0011095     Document Type: Article

References (63)

1. Ritz E, Rychlik I, Locatelli F, Halimi S (1999) End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions. Am J Kidney Dis 34: 795-808.
2. Oates PJ, Mylari BL (1999) Aldose reductase inhibitors: therapeutic implications for diabetic complications. Expert Opin Investig Drugs 8: 2095-2119.
3. Brownlee M, Cerami A, Vlassara H (1988) Advanced products of nonenzymatic glycosylation and the pathogenesis of diabetic vascular disease. Diabetes Metab Rev 4: 437-451.
4. Schmidt AM, Hori O, Cao R, Yan SD, Brett J, et al. (1996) RAGE: a novel cellular receptor for advanced glycation end products. Diabetes 45 Suppl 3: S77-S80.
5. Koya D, King GL (1998) Protein kinase C activation and the development of diabetic complications. Diabetes 47: 859-866.
6. Baynes JW, Thorpe SR (1999) Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 48: 1-9.
7. Szabo C (2005) Roles of poly(ADP-ribose) polymerase activation in the pathogenesis of diabetes mellitus and its complications. Pharmacol Res 52: 60-71.
8. Araki E, Oyadomari S, Mori M (2003) Endoplasmic reticulum stress and diabetes mellitus. Intern Med 42: 7-14.
9. Nishikawa T, Edelstein D, Brownlee M (2000) The missing link: a single unifying mechanism for diabetic complications. Kidney Int Suppl 77: S26-S30.
10. Burns KD (2000) Angiotensin II and its receptors in the diabetic kidney. Am J Kidney Dis 36: 449-467.
11. Williamson JR, Chang K, Frangos M, Hasan KS, Ido Y, et al. (1993) Hyperglycemic pseudohypoxia and diabetic complications. Diabetes 42: 801-813.
12. Strange K (2005) The end of ''naive reductionism'': rise of systems biology or renaissance of physiology? Am J Physiol Cell Physiol 288: C968-C974.
13. Gonzalez-Diaz H, Gonzalez-Diaz Y, Santana L, Ubeira FM, Uriarte E (2008) Proteomics, networks and connectivity indices. Proteomics 8: 750-778.
14. Mark M, Ghyselinck NB, Chambon P (2006) Function of retinoid nuclear receptors: lessons from genetic and pharmacological dissections of the retinoic acid signaling pathway during mouse embryogenesis. Annu Rev Pharmacol Toxicol 46: 451-480.
15. Noy N (2007) Ligand specificity of nuclear hormone receptors: sifting through promiscuity. Biochemistry 46: 13461-13467.
16. Napoli JL (1999) Interactions of retinoid binding proteins and enzymes in retinoid metabolism. Biochim Biophys Acta 1440: 139-162.
17. Graham TE, Yang Q, Bluher M, Hammarstedt A, Ciaraldi TP, et al. (2006) Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med 354: 2552-2563.
18. Kane MA, Chen N, Sparks S, Napoli JL (2005) Quantification of endogenous retinoic acid in limited biological samples by LC/MS/MS. Biochem J 388: 363-369.
19. Han SY, So GA, Jee YH, Han KH, Kang YS, et al. (2004) Effect of retinoic acid in experimental diabetic nephropathy. Immunol Cell Biol 82: 568-576.
20. Raza H, Prabu SK, Robin MA, Avadhani NG (2004) Elevated mitochondrial cytochrome P450 2E1 and glutathione S-transferase A4-4 in streptozotocininduced diabetic rats: tissue-specific variations and roles in oxidative stress. Diabetes 53: 185-194.
21. Ahn T, Yun CH, Oh DB (2006) Tissue-specific effect of ascorbic acid supplementation on the expression of cytochrome P450 2E1 and oxidative stress in streptozotocin-induced diabetic rats. Toxicol Lett 166: 27-36.
22. Shaw N, Elholm M, Noy N (2003) Retinoic acid is a high affinity selective ligand for the peroxisome proliferator-activated receptor beta/delta. J Biol Chem 278: 41589-41592.
23. Berry DC, Noy N (2009) All-trans-retinoic acid represses obesity and insulin resistance by activating both peroxisome proliferation-activated receptor beta/ delta and retinoic acid receptor. Mol Cell Biol 29: 3286-3296.
24. Rieck M, Meissner W, Ries S, Muller-Brusselbach S, Muller R (2008) Ligandmediated regulation of peroxisome proliferator-activated receptor (PPAR) beta/ delta: a comparative analysis of PPAR-selective agonists and all-trans retinoic acid. Mol Pharmacol 74: 1269-1277.
25. Sharma K, McCue P, Dunn SR (2003) Diabetic kidney disease in the db/db mouse. Am J Physiol Renal Physiol 284: F1138-F1144.
26. Starkey JM, Haidacher SJ, LeJeune WS, Zhang X, Tieu BC, et al. (2006) Diabetes-induced activation of canonical and noncanonical nuclear factorkappaB pathways in renal cortex. Diabetes 55: 1252-1259.
27. Qian WJ, Monroe ME, Liu T, Jacobs JM, Anderson GA, et al. (2005) Quantitative proteome analysis of human plasma following in vivo lipopolysaccharide administration using 16O/18O labeling and the accurate mass and time tag approach. Mol Cell Proteomics 4: 700-709.
28. Zhao Y, Denner L, Haidacher SJ, LeJeune WS, Tilton RG (2008) Comprehensive analysis of the mouse renal cortex using two-dimensional HPLC - tandem mass spectrometry. Proteome Sci 6: 15.
29. Tabb DL, McDonald WH, Yates JR, III (2002) DTASelect and Contrast: tools for assembling and comparing protein identifications from shotgun proteomics. J Proteome Res 1: 21-26.
30. Elias JE, Gygi SP (2007) Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry. Nat Methods 4: 207-214.
31. Yao X, Freas A, Ramirez J, Demirev PA, Fenselau C (2001) Proteolytic 18O labeling for comparative proteomics: model studies with two serotypes of adenovirus. Anal Chem 73: 2836-2842.
32. Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: A practical and powerful approach to multiple testing. Journal of the Royal Statistical Society Series B 57: 289-300.
33. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
34. Kane MA, Folias AE, Wang C, Napoli JL (2008) Quantitative profiling of endogenous retinoic acid in vivo and in vitro by tandem mass spectrometry. Anal Chem 80: 1702-1708.
35. Kane MA, Folias AE, Napoli JL (2008) HPLC/UV quantitation of retinal, retinol, and retinyl esters in serum and tissues. Anal Biochem 378: 71-79.
36. Duester G, Mic FA, Molotkov A (2003) Cytosolic retinoid dehydrogenases govern ubiquitous metabolism of retinol to retinaldehyde followed by tissuespecific metabolism to retinoic acid. Chem Biol Interact 143-144: 201-210.
37. Ziouzenkova O, Orasanu G, Sharlach M, Akiyama TE, Berger JP, et al. (2007) Retinaldehyde represses adipogenesis and diet-induced obesity. Nat Med 13: 695-702.
38. Boerman MH, Napoli JL (1996) Cellular retinol-binding protein-supported retinoic acid synthesis. Relative roles of microsomes and cytosol. J Biol Chem 271: 5610-5616.
39. Deltour L, Foglio MH, Duester G (1999) Metabolic deficiencies in alcohol dehydrogenase Adh1, Adh3, and Adh4 null mutant mice. Overlapping roles of Adh1 and Adh4 in ethanol clearance and metabolism of retinol to retinoic acid. J Biol Chem 274: 16796-16801.
40. Molotkov A, Fan X, Duester G (2002) Excessive vitamin A toxicity in mice genetically deficient in either alcohol dehydrogenase Adh1 or Adh3. Eur J Biochem 269: 2607-2612.
41. Posch KC, Burns RD, Napoli JL (1992) Biosynthesis of all-trans-retinoic acid from retinal. Recognition of retinal bound to cellular retinol binding protein (type I) as substrate by a purified cytosolic dehydrogenase. J Biol Chem 267: 19676-19682.
42. Elizondo G, Corchero J, Sterneck E, Gonzalez FJ (2000) Feedback inhibition of the retinaldehyde dehydrogenase gene ALDH1 by retinoic acid through retinoic acid receptor alpha and CCAAT/enhancer-binding protein beta. J Biol Chem 275: 39747-39753.
43. Elizondo G, Medina-Diaz IM, Cruz R, Gonzalez FJ, Vega L (2009) Retinoic acid modulates retinaldehyde dehydrogenase 1 gene expression through the induction of GADD153-C/EBPbeta interaction. Biochem Pharmacol 77: 248-257.
44. Basu TK, Tze WJ, Leichter J (1989) Serum vitamin A and retinol-binding protein in patients with insulin-dependent diabetes mellitus. Am J Clin Nutr 50: 329-331.
45. Martinoli L, Di FM, Seghieri G, Ciuti M, De Giorgio LA, et al. (1993) Plasma retinol and alpha-tocopherol concentrations in insulin-dependent diabetes mellitus: their relationship to microvascular complications. Int J Vitam Nutr Res 63: 87-92.
46. Olmedilla B, Granado F, Gil-Martinez E, Blanco I, Rojas-Hidalgo E (1997) Reference values for retinol, tocopherol, and main carotenoids in serum of control and insulin-dependent diabetic Spanish subjects. Clin Chem 43: 1066-1071.
47. Lu J, Dixon WT, Tsin AT, Basu TK (2000) The metabolic availability of vitamin A is decreased at the onset of diabetes in BB rats. J Nutr 130: 1958-1962.
48. Baena RM, Campoy C, Bayes R, Blanca E, Fernandez JM, et al. (2002) Vitamin A, retinol binding protein and lipids in type 1 diabetes mellitus. Eur J Clin Nutr 56: 44-50.
49. Wang XD (2005) Alcohol, vitamin A, and cancer. Alcohol 35: 251-258.
50. El-Serag HB, Hampel H, Javadi F (2006) The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. Clin Gastroenterol Hepatol 4: 369-380.
51. Njar VC, Gediya L, Purushottamachar P, Chopra P, Vasaitis TS, et al. (2006) Retinoic acid metabolism blocking agents (RAMBAs) for treatment of cancer and dermatological diseases. Bioorg Med Chem 14: 4323-4340.
52. Hennekens CH, Buring JE, Manson JE, Stampfer M, Rosner B, et al. (1996) Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 334: 1145-1149
53. Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, et al. (1996) Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 334: 1150-1155.
54. Wang Z, Hall SD, Maya JF, Li L, Asghar A, et al. (2003) Diabetes mellitus increases the in vivo activity of cytochrome P450 2E1 in humans. Br J Clin Pharmacol 55: 77-85.
55. Lieber CS (1997) Cytochrome P-4502E1: its physiological and pathological role. Physiol Rev 77: 517-544.
56. Bai J, Cederbaum AI (2006) Overexpression of CYP2E1 in mitochondria sensitizes HepG2 cells to the toxicity caused by depletion of glutathione. J Biol Chem 281: 5128-5136.
57. Wang T, Ma X, Krausz KW, Idle JR, Gonzalez FJ (2008) Role of pregnane X receptor in control of all-trans retinoic acid (ATRA) metabolism and its potential contribution to ATRA resistance. J Pharmacol Exp Ther 324: 674-684.
58. Schug TT, Berry DC, Shaw NS, Travis SN, Noy N (2007) Opposing effects of retinoic acid on cell growth result from alternate activation of two different nuclear receptors. Cell 129: 723-733.
59. Tilton RG, Haidacher SJ, LeJeune WS, Zhao Y, Kurosky A, Brasier AR, Denner LA (2007) Diabetes-induced changes in the renal cortical proteome assessed with two-dimensional gel electrophoresis and mass spectrometry. Proteomics 7: 1729-1742.
60. Mishra R, Emancipator SN, Miller C, Kern T, Simonson MS (2004) Adipose differentiation-related protein and regulators of lipid homeostasis identified by gene expression profiling in the murine db/db diabetic kidney. Am J Physiol Renal Physiol 286: F913-F921.
61. Dong D, Ruuska SE, Levinthal DJ, Noy N (1999) Distinct roles for cellular retinoic acid-binding proteins I and II in regulating signaling by retinoic acid. J Biol Chem 274: 23695-23698.
62. Proctor G, Jiang T, Iwahashi M, Wang Z, Li J, et al. (2006) Regulation of renal fatty acid and cholesterol metabolism, inflammation, and fibrosis in Akita and OVE26 mice with type 1 diabetes. Diabetes 55: 2502-2509.
63. Liu X, Lu L, Tao BB, Zhu YC (2008) All-trans retinoic acid inhibits the increases in fibronectin and PAI-1 induced by TGF-beta1 and Ang II in rat mesangial cells. Acta Pharmacol Sin 29: 1035-1041.